KCP3 inhibitors are a class of chemical compounds that specifically target the enzymatic activity of KCP3, a key regulatory component in cellular processes. KCP3 is involved in the modulation of protein-protein interactions, signaling cascades, and post-translational modifications, particularly within pathways related to cellular homeostasis. The inhibition of KCP3 can lead to significant alterations in molecular pathways, as it is often associated with the regulation of key enzymes and other proteins that control cell cycle, growth, and stress responses. KCP3 inhibitors can vary in their structure, ranging from small molecules to larger peptides, but all share the ability to bind to the active or regulatory site of the KCP3 protein, preventing it from fulfilling its normal biological role.
From a structural chemistry perspective, KCP3 inhibitors often display high specificity, with precise molecular interactions required for binding. Many of these compounds possess functional groups that enable hydrogen bonding, hydrophobic interactions, and even covalent modification of KCP3. These interactions are critical for the stabilization of the inhibitor-KCP3 complex, effectively blocking the enzyme's catalytic function. Structural studies often reveal that KCP3 inhibitors occupy distinct binding pockets or catalytic sites, and their design is frequently based on the detailed understanding of KCP3's structure. Modifications in the inhibitor's structure, such as the addition of functional groups or changes in the core scaffold, can significantly enhance the binding affinity and specificity for KCP3.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
By inhibiting tyrosine kinases, Genistein can affect signaling pathways that KCP3 might be involved in, potentially reducing its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An ERK pathway inhibitor. If KCP3 is involved in the ERK pathway, PD98059 can impede its related functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, affecting associated pathways where KCP3 may play a role. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor. Can influence pathways where KCP3 operates, potentially diminishing its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
As a p38 MAPK inhibitor, it can potentially impact pathways associated with KCP3. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor which can impede pathways related to KCP3's function. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator that can disturb calcium-dependent processes or pathways KCP3 might be involved in. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
As a CaMKII inhibitor, KN-93 can impede calcium/calmodulin-dependent pathways that involve KCP3. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
As a PKA inhibitor, H-89 can influence cyclic AMP-dependent pathways associated with KCP3. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
By inhibiting JAK2, it may affect pathways or processes related to KCP3's function. | ||||||